microdosing glp 1 weight loss GLP-1 for GLP-1 medications are changing how
Description
This article examines the emerging evidence, proposed mechanisms involving brain reward pathways, and important safety considerations for clinicians and patients navigating this investigational area
Orforglipron showed similar gastrointestinal side effects as other GLP-1 drugs, with the most common being diarrhea, nausea, indigestion, and constipation
Tijms, P
Less commonly, patients develop pretibial dermopathy and acropachy, reflecting fibroblast activation in the skin and extremities [21]
